Skip to main content
Hauptrubriken
CME Facharzt-Training Webinare Zeitschriften Bücher e.Medpedia Podcast
Service
Jobbörse Info & Hilfe
Fachgebiete
Anästhesiologie Allgemeinmedizin Arbeitsmedizin Augenheilkunde Chirurgie Dermatologie Gynäkologie und Geburtshilfe HNO Innere Medizin Kardiologie Neurologie Onkologie und Hämatologie Orthopädie und Unfallchirurgie Pädiatrie Pathologie Psychiatrie Radiologie Rechtsmedizin Urologie Zahnmedizin
Themen
Klimawandel und Gesundheit Neues aus dem Markt COVID-19 Praxis und Beruf Seltene Erkrankungen GOÄ & EBM Panorama
Sammlungen
Kasuistiken Algorithmen & Infografiken Blickdiagnosen Arthropedia FlapFinder (für Dermatochirurgen) Videos Kongressberichterstattung Medizin für Apothekerinnen und Apotheker Für Ärztinnen und Ärzte in Weiterbildung Für Medizinstudierende
Erweiterte Suche
Anmelden
nach oben
Acta Neurologica Belgica
Erschienen in: Acta Neurologica Belgica 3/2017

25.03.2017 | Review article

Neurological aspects of chemical and biological terrorism: guidelines for neurologists

verfasst von: Harald De Cauwer, Francis J. M. P. Somville, Marieke Joillet

Erschienen in: Acta Neurologica Belgica | Ausgabe 3/2017

Einloggen, um Zugang zu erhalten

Abstract

This statement paper deals with the key role an neurologist plays in the management of victims of chemical warfare/terrorist attacks. Because terrorist factions have expanded the war zone creating a worldwide risk of terrorist attacks, not only limited to some conflict zones in the Middle East, neurologists in all countries/regions have to be prepared for disaster response. The scope of this paper is to provide guidelines for the neurological management of victims of chemical and biological terrorist attacks.
Literatur
1.
De Cauwer H, Somville F, Sabbe M, Mortelmans LJ (2017) Hospitals: soft target for terrorism? Prehospital disaster medicine. Prehosp Disaster Med 32(1):94–100CrossRefPubMed
2.
3.
4.
Okudera H, Morita H, Iwashita T, Shibata T, Otagiri T, Kobayashi S, Yanagisawa N (1997) Unexpected nerve gas exposure in the city of Matsumoto: report of rescue activity in the first sarin gas terrorism. Am J Emerg Med 15(5):527–528CrossRefPubMed
5.
6.
7.
Mortelmans LJ, Van Boxstael S, De Cauwer HG, Sabbe MB (2014) Belgian Society of Emergency and Disaster Medicine (BeSEDiM) study. Preparedness of Belgian civil hospitals for chemical, biological, radiation, and nuclear incidents: are we there yet? Eur J Emerg Med 21(4):296–300CrossRefPubMed
8.
CDC Working Group (2000) Biological and chemical terrorism: strategic plan for preparedness and response. Recommendations of the CDC Strategic Planning Workgroup. MMWR Recomm Rep 49:1–14
9.
Barras V, Greub G (2014) History of biological warfare and bioterrorism. Clin Microbiol Infect 20(6):497–502CrossRefPubMed
10.
Cenciarelli O, Gabbarini V, Pietropaoli S, Malizia A, Tamburrini A, Ludovici GM et al (2015) Viral bioterrorism: Learning the lesson of Ebola virus in West Africa 2013–2015. Virus Res 210:318–326CrossRefPubMed
11.
Bus KM, Bleck TP (2012) Treatment of neuroterrorism. Neurotherapeutics. 9(1):139–157CrossRef
12.
Abramova FA, Grinberg LM, Yampolskaya OV, Walker DH (1993) Pathology of inhalational anthrax in 42 cases from the Sverdlovsk outbreak of 1979. Proc Natl Acad Sci USA 90(6):2291–2294CrossRefPubMedPubMedCentral
13.
Jernigan JA, Stephens DS, Ashford DA, Omenaca C, Topiel MS, Galbraith M et al (2001) Bioterrorism-related inhalational anthrax: the first 10 cases reported in the United States. Emerg Infect Dis 7(6):933–944CrossRefPubMedPubMedCentral
14.
15.
16.
Bush LM, Abrams BH, Beall A, Johnson CC (2001) Index case of fatal inhalation anthrax due to bioterrorism in the United States. N Engl J Med 345:1607–1610CrossRefPubMed
17.
18.
Kim HJ, Jun WB, Lee SH, Rho MH (2001) CT and MR findings of anthrax meningoencephalitis: report of two cases and review of the literature. AJNR Am J Neuroradiol 22:1303–1305PubMed
19.
Sejvar JJ, Tenover FC, Stephens DS (2005) Management of anthrax meningitis. Lancet Infect Dis 5(5):287–295CrossRefPubMed
20.
Inglesby TV, Henderson DA, Bartlett JG, Ascher MS, Eitzen E, Friedlander AM et al (1999) Anthrax as a biological weapon: medical and public health management. Working Group on Civilian Biodefense. JAMA 281(18):1735–1745CrossRefPubMed
21.
22.
Bower WA, Hendricks K, Pillai S, Guarnizo J, Meaney-Delman D (2015) Centers for Disease Control and Prevention (CDC). Clinical framework and medical countermeasure use during an anthrax mass-casualty incident. MMWR Recomm Rep 64(4):1–22CrossRefPubMed
23.
Katharios-Lanwermeyer S, Holty JE, Person M, Sejvar J, Haberling D, Tubbs H et al (2016) Identifying meningitis during an anthrax mass casualty incident: systematic review of systemic anthrax since 1880. Clin Infect Dis 62(12):1537–1545CrossRefPubMedPubMedCentral
24.
Erbguth FJ (2004) Historical notes on botulism, Clostridium botulinum, botulinum toxin, and the idea of the therapeutic use of the toxin. Mov Disord 19(Suppl 8):S2–S6CrossRefPubMed
25.
Caya JG, Agni R, Miller JE (2004) Clostridium botulinum and the clinical laboratorian: a detailed review of botulism, including biological warfare ramifications of botulinum toxin. Arch Pathol Lab Med 128(6):653–662PubMed
26.
Panicker JN, Muthane UB (2003) Botulinum toxins: pharmacology and its current therapeutic evidence for use. Neurol India 51(4):455–460PubMed
27.
Franz DR, Jahrling PB, Friedlander AM et al (1997) Clinical recognition and management of patients exposed to biological warfare agents. JAMA 278:399–411CrossRefPubMed
28.
Martin CO, Adams HP Jr (2003) Neurological aspects of biological and chemical terrorism: a review for neurologists. Arch Neurol 60:21–25CrossRefPubMed
29.
Arnon SS, Schechter R, Inglesby TV et al (2001) Botulinum toxin as a biological weapon: medical and public health management. JAMA 285:1059–1070CrossRefPubMed
30.
Noguchi T, Onuki K, Arakawa O (2011) Tetrodotoxin poisoning due to pufferfish and gastropods, and their intoxication mechanism. ISRN Toxicol 2011:276939CrossRefPubMedPubMedCentral
31.
Turner AD, Higgins C, Higman W, Hungerford J (2015) Potential threats posed by tetrodotoxins in UK waters: examination of detection methodology used in their control. Mar Drugs 13(12):7357–7376CrossRefPubMedPubMedCentral
32.
33.
Cole JB, Heegaard WG, Deeds JR, McGrath SC, Handy SM (2015) Centers for Disease Control and Prevention (CDC). Tetrodotoxin poisoning outbreak from imported dried puffer fish–Minneapolis, Minnesota, 2014. MMWR Morb Mortal Wkly Rep 63(51):1222–1225PubMed
34.
Bane V, Lehane M, Dikshit M, O’Riordan A, Furey A (2014) Tetrodotoxin: chemistry, toxicity, source, distribution and detection. Toxins (Basel) 6(2):693–755CrossRef
35.
Hajra A, Bandyopadhyay D, Hajra SK (2016) Zika virus: a global threat to humanity: a comprehensive review and current developments. N Am J Med Sci 8(3):123–128CrossRefPubMedPubMedCentral
36.
37.
Broutet N, Krauer F, Riesen M, Khalakdina A, Almiron M, Aldighieri S et al (2016) Zika virus as a cause of neurologic disorders. N Engl J Med 374(16):1506–1509CrossRefPubMed
38.
Petersen EE, Staples JE, Meaney-Delman D, Fischer M, Ellington SR, Callaghan WM et al (2016) Interim guidelines for pregnant women during a Zika virus outbreak-United States, 2016. MMWR Morb Mortal Wkly Rep 65:30–33CrossRefPubMed
39.
Baldacchino F, Caputo B, Chandre F, Drago A, Della Torre A, Montarsi F, Rizzoli A (2015) Control methods against invasive Aedes mosquitoes in Europe: a review. Pest Manag Sci 71(11):1471–1485CrossRefPubMed
40.
Scholte E, Den Hartog W, Dik M, Schoelitsz B, Brooks M, Schaffner F, Foussadier R, Braks M, Beeuwkes J (2010) Introduction and control of three invasive mosquito species in the Netherlands, July–October 2010. Euro Surveill 15(45)
41.
Brown CM, Aranas AE, Benenson GA, Brunette G, Cetron M, Chen TH et al (2014) Centers for Disease Control and Prevention (CDC). Airport exit and entry screening for Ebola—August–November 10, 2014. MMWR Morb Mortal Wkly Rep 63(49):1163–1167PubMed
42.
43.
Bray M (2003) Defense against filoviruses used as biological weapons. Antiviral Res 57(1–2):53–60CrossRefPubMed
44.
Cenciarelli O, Gabbarini V, Pietropaoli S, Malizia A, Tamburrini A, Ludovici GM et al (2015) Viral bioterrorism: Learning the lesson of Ebola virus in West Africa 2013–2015. Virus Res 210:318–326CrossRefPubMed
45.
46.
47.
Rosello A, Mossoko M, Flasche S, Van Hoek AJ, Mbala P, Camacho A et al (2015) Ebola virus disease in the Democratic Republic of the Congo, 1976–2014. eLife 4:e09015
48.
Osterholm MT, Moore KA, Kelley NS, Brosseau LM, Wong G, Murphy FA et al (2015) Transmission of Ebola viruses: what we know and what we do not know. MBio 6(2):e00137CrossRefPubMedPubMedCentral
49.
Jacobs M, Rodger A, Bell DJ, Bhagani S, Cropley I, Filipe A et al. (2016) Late Ebola virus relapse causing meningoencephalitis: a case report. Lancet 30(388):498–503CrossRef
50.
Howlett P, Brown C, Helderman T, Brooks T, Lisk D, Deen G, Solbrig M, Lado M, Leone S (2016) Ebola virus disease complicated by late-onset encephalitis and polyarthritis. Emerg Infect Dis 22(1):150–152CrossRefPubMedPubMedCentral
51.
Jacob H (1971) The neuropathology of the Marburg disease in man. In: Martini GA, Siegert R (eds) Marburg virus disease. Springer, Berlin, pp P54–P61CrossRef
52.
53.
Moshiri M, Darchini-Maragheh E, Balali-Mood M (2012) Advances in toxicology and medical treatment of chemical warfare nerve agents. Daru 20(1):81CrossRefPubMedPubMedCentral
54.
Weissman BA, Raveh L (2011) Multifunctional drugs as novel antidotes for organophosphates’ poisoning. Toxicology 290(2–3):149–155CrossRefPubMed
55.
Balali-Mood M, Balali-Mood K (2008) Neurotoxic disorders of organophosphorus compounds and their managements. Arch Iran Med 11(1):65–89PubMed
56.
Raveh L, Eisenkraft A, Weissman BA (2014) Caramiphen edisylate: an optimal antidote against organophosphate poisoning. Toxicology 325:115–124CrossRefPubMed
57.
58.
Mercey G, Verdelet T, Renou J, Kliachyna M, Baati R, Nachon F, Jean L, Renard PY (2012) Reactivators of acetylcholinesterase inhibited by organophosphorus nerve agents. Acc Chem Res 45(5):756–766CrossRefPubMed
59.
Aracava Y, Pereira EF, Akkerman M, Adler M, Albuquerque EX (2009) Effectiveness of donepezil, rivastigmine, and (±)huperzine A in counteracting the acute toxicity of organophosphorus nerve agents: comparison with galantamine. J Pharmacol Exp Ther 331(3):1014–1024CrossRefPubMedPubMedCentral
60.
Lavon O, Eisenkraft A, Blanca M, Raveh L, Ramaty E, Krivoy A et al (2015) Is rivastigmine safe as pretreatment against nerve agents poisoning? A pharmacological, physiological and cognitive assessment in healthy young adult volunteers. Neurotoxicology 49:36–44CrossRefPubMed
61.
Marrs TC (2004) The role of diazepam in the treatment of nerve agent poisoning in a civilian population. Toxicol Rev 23(3):145–157CrossRefPubMed
62.
Gilat E, Kadar T, Levy A, Rabinovitz I, Cohen G, Kapon Y et al (2005) Anticonvulsant treatment of sarin-induced seizures with nasal midazolam: an electrographic, behavioral, and histological study in freely moving rats. Toxicol Appl Pharmacol 209(1):74–85CrossRefPubMed
63.
Heffernan R, Mostashari F, Das D, Besculides M, Rodriguez C, Greenko J et al (2004) New York City syndromic surveillance systems. MMWR Suppl 53:23–27PubMed
64.
Das D, Weiss D, Mostashari F, Treadwell T, McQuiston J, Hutwagner L et al (2003) Enhanced drop-in syndromic surveillance in New York City following September 11, 2001. J Urban Health 80(2 Suppl 1):i76–i88PubMedPubMedCentral
65.
66.
Casebeer L, Andolsek K, Abdolrasulnia M, Green J, Weissman N, Pryor E et al (2006) Evaluation of an online bioterrorism continuing medical education course. J Contin Educ Health Prof 26(2):137–144CrossRefPubMed
67.
Cosgrove SE, Perl TM, Song X, Sisson SD (2005) Ability of physicians to diagnose and manage illness due to category A bioterrorism agents. Arch Intern Med 165(17):2002–2006CrossRefPubMed
Metadaten
Titel
Neurological aspects of chemical and biological terrorism: guidelines for neurologists
verfasst von
Harald De Cauwer
Francis J. M. P. Somville
Marieke Joillet
Publikationsdatum
25.03.2017
Verlag
Springer International Publishing
Erschienen in
Acta Neurologica Belgica / Ausgabe 3/2017
Print ISSN: 0300-9009
Elektronische ISSN: 2240-2993
DOI
https://doi.org/10.1007/s13760-017-0774-y

Weitere Artikel der Ausgabe 3/2017

Acta Neurologica Belgica 3/2017 Zur Ausgabe

Letter to the Editor

Catastrophic presentation of a patient with combined NMOSD and thrombotic thrombocytopenic purpura/hemolytic uremic syndrome: a case report

Original Article

Neuron-specific enolase levels as a marker for possible neuronal damage in idiopathic intracranial hypertension

Neuro-Images

Oculomotor nerve palsy and diffuse large B cell lymphoma

Original Article

EEG abnormalities and long term seizure outcome in high functioning autism

Letter to the Editor

Intravenous thrombolysis after reversal of dabigatran by idarucizumab: a moment to be a pioneer

Abstracts

Symposium “Brain plasticity in epilepsy”, Leuven, Belgium, 13–16 May 2017

Leitlinien kompakt für die Neurologie

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Kostenlos registrieren

Neu im Fachgebiet Neurologie

Akuter Schwindel: Wann lohnt sich eine MRT?

28.04.2024 Schwindel Nachrichten

Akuter Schwindel stellt oft eine diagnostische Herausforderung dar. Wie nützlich dabei eine MRT ist, hat eine Studie aus Finnland untersucht. Immerhin einer von sechs Patienten wurde mit akutem ischämischem Schlaganfall diagnostiziert.

Niedriger diastolischer Blutdruck erhöht Risiko für schwere kardiovaskuläre Komplikationen

25.04.2024 Hypotonie Nachrichten

Wenn unter einer medikamentösen Hochdrucktherapie der diastolische Blutdruck in den Keller geht, steigt das Risiko für schwere kardiovaskuläre Ereignisse: Darauf deutet eine Sekundäranalyse der SPRINT-Studie hin.

Frühe Alzheimertherapie lohnt sich

25.04.2024 AAN-Jahrestagung 2024 Nachrichten

Ist die Tau-Last noch gering, scheint der Vorteil von Lecanemab besonders groß zu sein. Und beginnen Erkrankte verzögert mit der Behandlung, erreichen sie nicht mehr die kognitive Leistung wie bei einem früheren Start. Darauf deuten neue Analysen der Phase-3-Studie Clarity AD.

Viel Bewegung in der Parkinsonforschung

25.04.2024 Parkinson-Krankheit Nachrichten

Neue arznei- und zellbasierte Ansätze, Frühdiagnose mit Bewegungssensoren, Rückenmarkstimulation gegen Gehblockaden – in der Parkinsonforschung tut sich einiges. Auf dem Deutschen Parkinsonkongress ging es auch viel um technische Innovationen.

Update Neurologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

Newsletter bestellen
Bildnachweise